Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/14056
Title: Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach
Authors: Sahu, Basanta Pravas
Keywords: Enterovirus 71;Immune simulation;Ligand-receptor docking;Reverse vaccinology
Issue Date: 2024
Publisher: Korean Vaccine Society
Citation: Swain, S. K., Panda, S., Sahu, B. P., Mahapatra, S. R., Dey, J., Sarangi, R., & Misra, N. (2024). Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: A reverse vaccinology approach. Clinical and Experimental Vaccine Research. Scopus. https://doi.org/10.7774/cevr.2024.13.2.132
Abstract: Purpose: Enterovirus 71, a pathogen that causes hand-foot and mouth disease (HFMD) is currently regarded as an increasing neurotropic virus in Asia and can cause severe com-plications in pediatric patients with blister-like sores or rashes on the hand, feet, and mouth. Notwithstanding the significant burden of the disease, no authorized vaccine is available. Previously identified attenuated and inactivated vaccines are worthless over time owing to changes in the viral genome. Materials and Methods: A novel vaccine construct using B-cell derived T-cell epitopes from the virulent polyprotein found the induction of possible immune response. In order to boost the immune system, a beta-defensin 1 preproprotein adjuvant with EAAAK linker was added at the N-terminal end of the vaccine sequence. Results: The immunogenicity of the designed, refined, and verified prospective three-dimensional-structure of the multi-epitope vaccine was found to be quite high, exhibiting non-allergenic and antigenic properties. The vaccine candidates bound to toll-like receptor 3 in a molecular docking analysis, and the efficacy of the potential vaccine to generate a strong immune response was assessed through in silico immunological simulation. Conclusion: Computational analysis has shown that the proposed multi-epitope vaccine is possibly safe for use in humans and can elicit an immune response. © 2024, Korean Vaccine Society. All rights reserved.
URI: https://doi.org/10.7774/cevr.2024.13.2.132
https://dspace.iiti.ac.in/handle/123456789/14056
ISSN: 2287-3651
Type of Material: Journal Article
Appears in Collections:Department of Biosciences and Biomedical Engineering

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: